Skip to main content

Table 1 Summary of clinical information from the datasets used in the analysis

From: Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer

 

Training cohort

Validation cohorts

TCGA (362)

NODE (159)

ICGC (231)

status (%)

 alive

233 (64.4)

103 (64.8)

188 (81.4)

 dead

129 (35.6)

56 (35.2)

43 (18.6)

time (mean (SD))

2.22

2.66 (1.11)

67.20 (10.12)

age (mean (SD))

59.52

53.69 (10.90)

2.22 (1.14)

stage (%)

 I&II

254 (70.2)

105 (66.0)

141 (61.0)

 III&IV

84 (23.2)

54 (34.0)

90 (39.0)

 NA

24 (6.6)

-

-

gender (%)

 female

118 (32.6)

31 (19.5)

61 (26.4)

 male

244 (67.4)

128 (80.5)

170 (73.6)

T_stage (%)

 T1&T2

271 (74.9)

-

-

 T3&T4

88 (24.3)

-

-

 NA

3 (0.8)

-

-

bmi (mean (SD))

26.14 (8.47)

-

-

tumor_grade (%)

 G1

55 (15.2)

-

-

 G2

174 (48.1)

-

-

 G3

116 (32.0)

-

-

 G4

12 (3.3)

-

-

 NA

5 (1.4)

-

-